Findings

What do systematic reviews say?

1 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 33.3%High 2 · 66.7%

Non‐vitamin‐K‐antagonist oral anticoagulants vs placebo

Rivaroxaban (all doses combined) vs placebo · adults after AMI without an indication for anticoagulation

3 findings from 1 review

Non‐vitamin‐K‐antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta‐analysis 2024 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 21870 participants
High
Non‐vitamin‐K‐antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta‐analysis 2024 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 21870 participants
Moderate
Non‐vitamin‐K‐antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta‐analysis 2024 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 21870 participants
High